Short Interest in Helius Medical Technologies, Inc. (NASDAQ:HSDT) Rises By 58.6%

Helius Medical Technologies, Inc. (NASDAQ:HSDT) saw a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 106,600 shares, an increase of 58.6% from the May 15th total of 67,200 shares. Based on an average daily trading volume, of 423,700 shares, the days-to-cover ratio is presently 0.3 days.

Helius Medical Technologies Stock Performance

Shares of HSDT opened at $1.01 on Friday. The stock’s 50-day moving average price is $2.79 and its 200-day moving average price is $5.27. Helius Medical Technologies has a 52 week low of $1.00 and a 52 week high of $13.43.

Helius Medical Technologies (NASDAQ:HSDT) last announced its quarterly earnings results on Monday, May 13th. The company reported ($3.08) earnings per share for the quarter. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative return on equity of 297.49%. The business had revenue of $0.14 million during the quarter.

Analysts Set New Price Targets

Separately, Roth Mkm raised their target price on Helius Medical Technologies to $24.00 and gave the stock a “buy” rating in a research note on Tuesday, March 5th.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.